Here's a look at some of the top regulatory stories for medical device companies this week: Olympus sold 'superbug' scopes without our clearance; FDA clears 1 Hospira plant, flags another; GI Dynamics plunges 50% after FDA halts trial; Sunshine Heart stops trial enrollment after patient deaths; Petition accuses Bayer's Conceptus of altering Essure trial data
FDA: Olympus sold 'superbug' scopes without our clearance
March 5, 2015 by Brad Perriello
Bayer HealthCare, Conceptus Inc., Food & Drug Administration (FDA), Fujifilm Holdings, Hospira Inc., Olympus, Pentax, Ricoh Co., Sunshine Heart Inc., GI Dynamics
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1MoEp9L
Cap comentari:
Publica un comentari a l'entrada